Top compounds associated with response to NCOA5


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC 0.011 0.7
mRNA tosedostat CTRPv2 pan-cancer AAC 0.098 0.01
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.092 0.003
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.0043 0.9
mRNA triptolide CTRPv2 pan-cancer AAC 0.025 0.5
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.082 0.009
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.13 0.009
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.085 0.02
Download CSV